LAPTM4B and hepatocellular carcinoma: Evidences suggested that the overexpression of LAPTM4B may promote malignant transformation and enhance the metastasis and recurrence of HCC via activating AKT signaling pathway and some proto-oncogenes such as c-myc, c-jun and c-fos [49, 50].